Developing a Preclinical Nurse-Nurse Communication Framework for Clinical Trial Patient-Related Safety Information

dc.contributor.authorJohnson, Elizabeth A.
dc.contributor.authorRainbow, Jessica G.
dc.contributor.authorReed, Pamela G.
dc.contributor.authorGephart, Sheila M.
dc.contributor.authorCarrington, Jane M.
dc.date.accessioned2023-04-12T22:38:41Z
dc.date.available2023-04-12T22:38:41Z
dc.date.issued2022-11
dc.descriptionThis is a pre-copyedited, author-produced version of an article accepted for publication in CIN: Computers, Informatics, Nursing. The published version of record [Developing a Preclinical Nurse-Nurse Communication Framework for Clinical Trial Patient-Related Safety Information. CIN: Computers, Informatics, Nursing Publish Ahead of Print (2022)] is available online at: 10.1097/CIN.0000000000000968.en_US
dc.description.abstractClinical trial trials have become increasingly complex in their design and implementation. Investigational safety profiles are not easily accessed by clinical nurses and providers when trial participants present for clinical care, such as in emergency or urgent care. Wearable devices are now commonly used as bridging technologies to obtain participant data and house investigational product safety information. Clinical nurse identification and communication of safety information are critical to dissuade adverse events, patient injury, and trial withdrawal, which may occur when clinical care is misaligned to a research protocol. Based on a feasibility study and follow-up wearable device prototype study, this preclinical nurse-nurse communication framework guides clinical nurse verbal and nonverbal communication of safety-related trial information to direct patient care activities in the clinical setting. Communication and information theories are incorporated with Carrington's Nurse-to-Nurse Communication Framework to encompass key components of a clinical nurse's management of a trial participant safety event when a clinical trial wearable device is encountered during initial assessment. Use of the preclinical nurse-nurse communication framework may support clinical nurse awareness of trial-related wearable devices. The framework may further emphasize the importance of engaging with research nurses, patients, and caregivers to acquire trial safety details impacting clinical care decision-making.en_US
dc.identifier.citationJohnson, Elizabeth A. PhD, MS-CRM, RN; Rainbow, Jessica G. PhD, RN; Reed, Pamela G. PhD, RN, FAAN; Gephart, Sheila M. PhD, RN, FAAN; Carrington, Jane M. PhD, RN, FAAN, FAMIA. Developing a Preclinical Nurse-Nurse Communication Framework for Clinical Trial Patient-Related Safety Information. CIN: Computers, Informatics, Nursing ():10.1097/CIN.0000000000000968, November 4, 2022. | DOI: 10.1097/CIN.0000000000000968en_US
dc.identifier.issn1538-9774
dc.identifier.urihttps://scholarworks.montana.edu/handle/1/17799
dc.language.isoen_USen_US
dc.publisherOvid Technologiesen_US
dc.rightscopyright Ovid Technologies 2022en_US
dc.rights.urihttps://web.archive.org/web/20200107112139/https://cdn-tp2.mozu.com/16833-m1/cms/files/Author-Document.pdf?_mzts=636519775710000000en_US
dc.subjectpreclinical nurseen_US
dc.subjectnurse communicationen_US
dc.titleDeveloping a Preclinical Nurse-Nurse Communication Framework for Clinical Trial Patient-Related Safety Informationen_US
dc.typeArticleen_US
mus.citation.extentfirstpage1en_US
mus.citation.extentlastpage23en_US
mus.citation.journaltitleCIN: Computers, Informatics, Nursingen_US
mus.identifier.doi10.1097/CIN.0000000000000968en_US
mus.relation.collegeCollege of Nursingen_US
mus.relation.departmentNursing.en_US
mus.relation.universityMontana State University - Bozemanen_US

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
johnson-clinical-2022.pdf
Size:
334.89 KB
Format:
Adobe Portable Document Format
Description:
preclinical nurse

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Copyright (c) 2002-2022, LYRASIS. All rights reserved.